Researchers suggest that tailoring interventions to symptom clusters and chemotherapy course may be best management strategy.

For patients with intraductal carcinoma of the prostate (IDC-P), prostate-specific membrane antigen positron emission tomography (PSMA PET) may not show intraprostatic uptake — even in high-grade ...

“ur finding enables the safe discontinuation of follow-up after 6 years, leading to an improvement in quality of life and a reduction in health care system costs,” study researchers wrote.

Association between continued smoking and all-cause mortality also seen in patients with advanced-stage cancer. HealthDay News — For cancer survivors, postdiagnosis smoking cessation is associated ...

Current smoking was the most important predictor for a detrimental effect of aspirin on cancer incidence, whereas CHIP was the most important predictor for a beneficial effect of aspirin,” researchers ...

We demonstrate that patients with luminal B tumors derive clinically meaningful benefits … from the addition of apalutamide to secondary radiotherapy,” Dr Daniel Spratt said, adding that these ...

Standardized evaluation protocol improved transfer, ECSL outcomes, and re-transfer to discharge for pediatric hematologic oncology patients.

HealthDay News — More severe exposures to World Trade Center (WTC) dust increase the risk for developing lung cancer, according to a study published online Oct. 9 in JAMA Network Open.

Taken together with previous observational, genomic, and early trial data, our findings support the integration of aspirin into clinical practice for a molecularly defined subgroup of patients with ...

Researchers compared HRQoL outcomes, measured by patient-reported outcomes, among frail patients with newly diagnosed MM who received Isa-VRd vs VRd alone.

Since its approval, there have been no cases of torsades de pointes or unexplained sudden death among US patients treated with Caprelsa.

This is likely the first case report on primary cutaneous follicle center lymphoma associated with bone marrow mastocytosis.